Cathryn R. Nagler
https://pme.uchicago.edu/faculty/cathryn-nagler
https://microbiome.uchicago.edu/directory/cathryn-nagler
https://naglerlab.uchicago.edu/
Cathryn R. Nagler is the Bunning Family Professor in the Pritzker School of Molecular Engineering, the Department of Pathology and the College at the University of Chicago. Prof. Nagler’s research interests encompass the mechanisms governing tolerance to dietary antigens and the ability of intestinal bacteria to regulate susceptibility to allergic responses to food. She has applied insights gained from studying pre-clinical gnotobiotic murine models of cow’s milk allergy to launch a new company, ClostraBio, Inc., which is developing microbiome-modulating therapeutics for the prevention and treatment of food allergy.
Prof. Nagler serves in national and international leadership roles, many of which are related to publication and teaching, for the American Association of Immunologists, the Society for Mucosal Immunology and Federation of Clinical Immunology Societies. She also participates in numerous review panels. She received the Distinguished Faculty Award for Leadership in Program Innovation from the University of Chicago in 2017 and was listed among Crain’s Chicago Business 'Tech Top 50 Women in 2018' for her work with her academic start-up company ClostraBio. Recent academic honors include the American Academy of Allergy, Asthma and Immunology (AAAAI) Foundation and Louis M. Mendelson Award Lectureship and the Siegel Lectureship at UCLA.
Prof. Nagler was elected as a distinguished fellow of the American Association of Immunologists in 2020.
